Novavax COVID-19 vaccine provisionally approved for use in Australia
與目前本地使用的幾款新冠疫苗，包括阿斯利康（AstraZenaca）、兩款信使核糖核酸mRNA疫苗，輝瑞（Pfizer）及莫德納（Moderna）比較，Novavax的不良反應相對較輕微 Source: AAP
A new COVID-19 vaccine has been provisionally approved for use in Australia, joining Pfizer, Moderna, and AstraZeneca. The Novavax vaccine has shown promising results in clinical trials, and there are hopes the approval will convince some vaccine-hesitant people to finally get inoculated.
Share
